ENTITY

FibroBiologics (FBLG US)

10
Analysis
Health Care • United States
FibroBiologics, Inc. operates as an early stage, cell therapy company. The Company develops food and drug administration trials related to fibroblast treatments for degenerative disc disease, multiple sclerosis, cancer, wound healing, and other diseases. FibroBiologics serves clients in the United States.
more
Exchange Announcement • 06 May 2026 19:02
Exchange Announcement • 05 May 2026 19:21
Exchange Announcement • 02 May 2026 04:03
Exchange Announcement • 02 May 2026 04:01
x